These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38806101)
21. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790 [TBL] [Abstract][Full Text] [Related]
22. Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation. Pecnard S; Provot O; Levaique H; Bignon J; Askenatzis L; Saller F; Borgel D; Michallet S; Laisne MC; Lafanechère L; Alami M; Hamze A Eur J Med Chem; 2021 Jan; 209():112873. PubMed ID: 33038796 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors. Wang G; Liu W; Fan M; He M; Li Y; Peng Z J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1694-1702. PubMed ID: 34309466 [TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of aminostilbene-arylpropenones as tubulin polymerization inhibitors. Kamal A; Kumar GB; Polepalli S; Shaik AB; Reddy VS; Reddy MK; Reddy ChR; Mahesh R; Kapure JS; Jain N ChemMedChem; 2014 Nov; 9(11):2565-79. PubMed ID: 25146959 [TBL] [Abstract][Full Text] [Related]
25. β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells. Malebari AM; Fayne D; Nathwani SM; O'Connell F; Noorani S; Twamley B; O'Boyle NM; O'Sullivan J; Zisterer DM; Meegan MJ Eur J Med Chem; 2020 Mar; 189():112050. PubMed ID: 31954879 [TBL] [Abstract][Full Text] [Related]
26. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. Hagras M; El Deeb MA; Elzahabi HSA; Elkaeed EB; Mehany ABM; Eissa IH J Enzyme Inhib Med Chem; 2021 Dec; 36(1):640-658. PubMed ID: 33588683 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors. Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171 [TBL] [Abstract][Full Text] [Related]
28. Discovery of novel amide derivatives against VEGFR-2/tubulin with potent antitumor and antiangiogenic activity. Liu Z; Mao S; Li H; Liu W; Tao J; Lu Y; Dong H; Zhang J; Song C; Duan Y; Yao Y Bioorg Chem; 2024 Oct; 151():107679. PubMed ID: 39094510 [TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker. Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues. Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of 4-phenyl-5-quinolinyl substituted isoxazole analogues as potent cytotoxic and tubulin polymerization inhibitors against ESCC. Jia M; Pei Y; Li N; Zhang Y; Song J; Niu JB; Yang H; Zhang S; Sun M Eur J Med Chem; 2024 Sep; 275():116611. PubMed ID: 38901104 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S; An B; Li Y; Luo X; Li X; Jia X Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological evaluation, and structure-activity relationships of new tubulin polymerization inhibitors based on 5-amino-1,2,4-triazole scaffold. Yang F; Chen L; Lai JM; Jian XE; Lv DX; Yuan LL; Liu YX; Liang FT; Zheng XL; Li XL; Wei LY; You WW; Zhao PL Bioorg Med Chem Lett; 2021 Apr; 38():127880. PubMed ID: 33636303 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities. Ren Y; Ruan Y; Cheng B; Li L; Liu J; Fang Y; Chen J Bioorg Med Chem; 2021 Sep; 46():116376. PubMed ID: 34455231 [TBL] [Abstract][Full Text] [Related]
35. Anti-proliferative potential of triphenyl substituted pyrimidines against MDA-MB-231, HCT-116 and HT-29 cancer cell lines. Ranjan Dwivedi A; Kumar V; Kaur H; Kumar N; Prakash Yadav R; Poduri R; Baranwal S; Kumar V Bioorg Med Chem Lett; 2020 Oct; 30(20):127468. PubMed ID: 32768647 [TBL] [Abstract][Full Text] [Related]
36. Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines. Huo XS; Jian XE; Ou-Yang J; Chen L; Yang F; Lv DX; You WW; Rao JJ; Zhao PL Eur J Med Chem; 2021 Aug; 220():113449. PubMed ID: 33895499 [TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors. Liang T; Zhou X; Lu L; Dong H; Zhang Y; Xu Y; Qi J; Zhang Y; Wang J Bioorg Chem; 2021 May; 110():104793. PubMed ID: 33770673 [TBL] [Abstract][Full Text] [Related]
38. Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors. Kamal A; Srikanth PS; Vishnuvardhan MV; Kumar GB; Suresh Babu K; Hussaini SM; Kapure JS; Alarifi A Bioorg Chem; 2016 Apr; 65():126-36. PubMed ID: 26943479 [TBL] [Abstract][Full Text] [Related]